702 related articles for article (PubMed ID: 27593869)
1. Antibody to FcεRIα Suppresses Immunoglobulin E Binding to High-Affinity Receptor I in Allergic Inflammation.
Hong JY; Bae JH; Lee KE; Kim M; Kim MH; Kang HJ; Park EH; Yoo KS; Jeong SK; Kim KW; Kim KE; Sohn MH
Yonsei Med J; 2016 Nov; 57(6):1412-9. PubMed ID: 27593869
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of antigen-induced mediator release from IgE-sensitized cells by a monoclonal anti-Fc epsilon RI alpha-chain receptor antibody: implications for the involvement of the membrane-proximal alpha-chain region in Fc epsilon RI-mediated cell activation.
Nechansky A; Robertson MW; Albrecht BA; Apgar JR; Kricek F
J Immunol; 2001 May; 166(10):5979-90. PubMed ID: 11342613
[TBL] [Abstract][Full Text] [Related]
3. The Fab fragment of anti-IgE Cε2 domain prevents allergic reactions through interacting with IgE-FcεRIα complex on rat mast cells.
Hirano T; Koyanagi A; Kotoshiba K; Shinkai Y; Kasai M; Ando T; Kaitani A; Okumura K; Kitaura J
Sci Rep; 2018 Sep; 8(1):14237. PubMed ID: 30250145
[TBL] [Abstract][Full Text] [Related]
4. Rapid polyclonal desensitization with antibodies to IgE and FcεRIα.
Khodoun MV; Kucuk ZY; Strait RT; Krishnamurthy D; Janek K; Lewkowich I; Morris SC; Finkelman FD
J Allergy Clin Immunol; 2013 Jun; 131(6):1555-64. PubMed ID: 23632296
[TBL] [Abstract][Full Text] [Related]
5. A novel bispecific DARPin targeting FcγRIIB and FcεRI-bound IgE inhibits allergic responses.
Zellweger F; Gasser P; Brigger D; Buschor P; Vogel M; Eggel A
Allergy; 2017 Aug; 72(8):1174-1183. PubMed ID: 27997998
[TBL] [Abstract][Full Text] [Related]
6. Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cells.
Eggel A; Baravalle G; Hobi G; Kim B; Buschor P; Forrer P; Shin JS; Vogel M; Stadler BM; Dahinden CA; Jardetzky TS
J Allergy Clin Immunol; 2014 Jun; 133(6):1709-19.e8. PubMed ID: 24642143
[TBL] [Abstract][Full Text] [Related]
7. Targeting Mast Cells and Basophils with Anti-FcεRIα Fab-Conjugated Celastrol-Loaded Micelles Suppresses Allergic Inflammation.
Peng X; Wang J; Li X; Lin L; Xie G; Cui Z; Li J; Wang Y; Li L
J Biomed Nanotechnol; 2015 Dec; 11(12):2286-99. PubMed ID: 26510321
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of IgE-dependent histamine release from human peripheral blood basophils by humanized Fab fragments that recognize the membrane proximal domain of the human Fc epsilon RI alpha-chain.
Takai T; Yuuki T; Ra C
Int Arch Allergy Immunol; 2000 Dec; 123(4):308-18. PubMed ID: 11146388
[TBL] [Abstract][Full Text] [Related]
9. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
[TBL] [Abstract][Full Text] [Related]
10. Blocking Allergic Reaction through Targeting Surface-Bound IgE with Low-Affinity Anti-IgE Antibodies.
Zhang K; Liu J; Truong T; Zukin E; Chen W; Saxon A
J Immunol; 2017 May; 198(10):3823-3834. PubMed ID: 28396318
[TBL] [Abstract][Full Text] [Related]
11. IgE-dependent and IgE-independent stimulation of human basophils increases the presence of immature FcεRIα by reversing degradative pathways.
Zaidi AK; MacGlashan D
Int Arch Allergy Immunol; 2011; 154(1):15-24. PubMed ID: 20664273
[TBL] [Abstract][Full Text] [Related]
12. IL-3 but not monomeric IgE regulates FcεRI levels and cell survival in primary human basophils.
Zellweger F; Buschor P; Hobi G; Brigger D; Dahinden CA; Villiger PM; Eggel A
Cell Death Dis; 2018 May; 9(5):510. PubMed ID: 29724998
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of allergen-specific IgE reactivity by a human Ig Fcgamma-Fcepsilon bifunctional fusion protein.
Zhang K; Kepley CL; Terada T; Zhu D; Perez H; Saxon A
J Allergy Clin Immunol; 2004 Aug; 114(2):321-7. PubMed ID: 15316510
[TBL] [Abstract][Full Text] [Related]
14. SLAP Is a Negative Regulator of FcεRI Receptor-Mediated Signaling and Allergic Response.
Sharma N; Ponce M; Kaul S; Pan Z; Berry DM; Eiwegger T; McGlade CJ
Front Immunol; 2019; 10():1020. PubMed ID: 31156621
[TBL] [Abstract][Full Text] [Related]
15. Current Strategies to Inhibit High Affinity FcεRI-Mediated Signaling for the Treatment of Allergic Disease.
Gomez G
Front Immunol; 2019; 10():175. PubMed ID: 30792720
[TBL] [Abstract][Full Text] [Related]
16. A Co-Expressed Natural Antisense RNA
Tang RY; Yin L; Yao L; Zhang QF; Chen XP
Microbiol Spectr; 2023 Jun; 11(3):e0073323. PubMed ID: 37154775
[TBL] [Abstract][Full Text] [Related]
17. A molecular model of type I allergy: identification and characterization of a nonanaphylactic anti-human IgE antibody fragment that blocks the IgE-FcepsilonRI interaction and reacts with receptor-bound IgE.
Laffer S; Hogbom E; Roux KH; Sperr WR; Valent P; Bankl HC; Vangelista L; Kricek F; Kraft D; Grönlund H; Valenta R
J Allergy Clin Immunol; 2001 Sep; 108(3):409-16. PubMed ID: 11544461
[TBL] [Abstract][Full Text] [Related]
18. Rat monoclonal anti-murine IgE antibody removes IgE molecules already bound to mast cells or basophilic leukemia cells, resulting in the inhibition of systemic anaphylaxis and passive cutaneous anaphylaxis.
Miyajima H; Watanabe N; Ovary Z; Okumura K; Hirano T
Int Arch Allergy Immunol; 2002 May; 128(1):24-32. PubMed ID: 12037398
[TBL] [Abstract][Full Text] [Related]
19. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
[TBL] [Abstract][Full Text] [Related]
20. The anti-IgE/anti-FcepsilonRIalpha autoantibody network in allergic and autoimmune diseases.
Marone G; Spadaro G; Palumbo C; Condorelli G
Clin Exp Allergy; 1999 Jan; 29(1):17-27. PubMed ID: 10051698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
